Vermillion EPS - Earnings per Share 2006-2019 | VRML

Vermillion eps - earnings per share from 2006 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Vermillion Annual EPS
2018 $-0.16
2017 $-0.20
2016 $-0.29
2015 $-0.41
2014 $-0.53
2013 $-0.42
2012 $-0.48
2011 $-1.25
2010 $-1.83
2009 $-3.31
2008 $-2.87
2007 $0.00
2006 $0.00
2005 $0.00
Vermillion Quarterly EPS
Q3 2019 $-0.04
Q2 2019 $-0.06
Q1 2019 $-0.05
Q4 2018 $-0.03
Q3 2018 $-0.04
Q2 2018 $-0.04
Q1 2018 $-0.05
Q4 2017 $-0.05
Q3 2017 $-0.06
Q2 2017 $-0.04
Q1 2017 $-0.05
Q4 2016 $-0.06
Q3 2016 $-0.07
Q2 2016 $-0.07
Q1 2016 $-0.09
Q4 2015 $-0.10
Q3 2015 $-0.10
Q2 2015 $-0.11
Q1 2015 $-0.10
Q4 2014 $-0.11
Q3 2014 $-0.16
Q2 2014 $-0.15
Q1 2014 $-0.11
Q4 2013 $-0.04
Q3 2013 $-0.10
Q2 2013 $-0.11
Q1 2013 $-0.17
Q4 2012 $-0.10
Q3 2012 $-0.13
Q2 2012 $-0.13
Q1 2012 $-0.12
Q4 2011 $-0.21
Q3 2011 $-0.31
Q2 2011 $-0.39
Q1 2011 $-0.34
Q4 2010 $-0.38
Q3 2010 $-0.26
Q2 2010 $-0.07
Q1 2010 $-1.14
Q4 2009 $-0.86
Q3 2009 $-1.72
Q2 2009 $-0.28
Q1 2009 $-0.44
Q4 2008 $0.00
Q3 2008 $0.00
Q2 2008 $0.00
Q1 2008 $0.00
Q4 2007 $0.00
Q3 2007 $0.00
Q2 2007 $0.00
Q1 2007 $0.00
Q4 2006 $0.00
Q3 2006 $0.00
Q2 2006 $0.00
Q1 2006 $0.00
Q4 2005 $0.00
Q3 2005 $0.00
Q2 2005 $0.00
Q1 2005 $0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.078B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $136.012B 28.17
Intuitive Surgical (ISRG) United States $69.348B 54.50
Edwards Lifesciences (EW) United States $49.773B 45.20
IDEXX Laboratories (IDXX) United States $24.517B 59.29
Fresenius Medical Care AG KGaA (FMS) Germany $22.773B 15.41
Olympus (OCPNY) Japan $22.330B 0.00
DexCom (DXCM) United States $21.124B 189.17
Teleflex (TFX) United States $17.765B 36.06
SONOVA HOLDING (SONVY) Switzerland $15.277B 0.00
Sysmex ADR (SSMXY) Japan $14.597B 39.29
Hologic (HOLX) United States $14.566B 22.26
Varian Medical Systems (VAR) United States $13.545B 32.11
STERIS (STE) Ireland $13.068B 28.86
Masimo (MASI) United States $9.053B 54.06
ABIOMED (ABMD) United States $8.186B 44.54
SARTORIUS AG (SARTF) Germany $6.731B 59.08
Penumbra (PEN) United States $5.599B 182.23
Globus Medical (GMED) United States $5.299B 32.70
Integra LifeSciences Holdings (IART) United States $5.077B 21.82
Elekta AB (EKTAY) Sweden $4.535B 38.29
Tandem Diabetes Care (TNDM) United States $4.053B 0.00
Wright Medical Group (WMGI) Netherlands $3.820B 231.54
Nevro (NVRO) United States $3.752B 0.00
LivaNova (LIVN) United Kingdom $3.547B 25.53
Integer Holdings (ITGR) United States $2.909B 19.92
Cantel Medical (CMD) United States $2.659B 26.02
Nihon Kohden (NHNKY) Japan $2.458B 24.73
Glaukos (GKOS) United States $2.088B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.588B 31.26
Veracyte (VCYT) United States $1.473B 0.00
Silk Road Medical (SILK) United States $1.322B 0.00
Natus Medical (NTUS) United States $1.170B 28.14
Mesa Laboratories (MLAB) United States $1.159B 42.97
Tactile Systems Technology (TCMD) United States $1.157B 132.22
CryoLife (CRY) United States $1.125B 115.35
Inogen (INGN) United States $1.087B 34.33
Luminex (LMNX) United States $1.044B 0.00
OPKO Health (OPK) United States $1.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.945B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.894B 29.71
OrthoPediatrics (KIDS) United States $0.799B 0.00
Intersect ENT (XENT) United States $0.771B 0.00
Pacific Biosciences Of California (PACB) United States $0.762B 0.00
Quotient (QTNT) Switzerland $0.686B 0.00
AngioDynamics (ANGO) United States $0.582B 26.69
AxoGen (AXGN) United States $0.565B 0.00
Si-Bone (SIBN) United States $0.544B 0.00
Alphatec Holdings (ATEC) United States $0.456B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.427B 12.92
Sientra (SIEN) United States $0.379B 0.00
Semler Scientific (SMLR) United States $0.327B 45.46
RTI Surgical (RTIX) United States $0.326B 88.20
ViewRay (VRAY) United States $0.310B 0.00
SeaSpine Holdings (SPNE) United States $0.303B 0.00
IRadimed (IRMD) United States $0.301B 42.34
Fluidigm (FLDM) United States $0.294B 0.00
Accuray (ARAY) United States $0.292B 0.00
GenMark Diagnostics (GNMK) United States $0.288B 0.00
Restoration Robotics (VERO) Canada $0.171B 0.00
Spectral Diagnostics (EDTXF) Canada $0.127B 0.00
EDAP TMS S.A (EDAP) France $0.119B 31.54
ConforMIS (CFMS) United States $0.087B 0.00
Neuronetics (STIM) United States $0.082B 0.00
Second Sight Medical Products (EYES) United States $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.070B 0.00
Bioanalytical Systems (BASI) United States $0.063B 0.00
Apollo Endosurgery (APEN) United States $0.060B 0.00
T2 Biosystems (TTOO) United States $0.055B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.038B 0.00
Helius Medical Technologies (HSDT) United States $0.034B 0.00
Neovasc (NVCN) Canada $0.029B 0.00
Ekso Bionics Holdings (EKSO) United States $0.027B 0.00
Ra Medical Systems (RMED) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.015B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.012B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00